{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:35:27Z","timestamp":1790044527574,"version":"4.0.1"},"reference-count":115,"publisher":"Japanese Society of Toxicology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2025]]},"DOI":"10.2131\/jts.50.245","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T22:11:41Z","timestamp":1748729501000},"page":"245-261","source":"Crossref","is-referenced-by-count":4,"title":["An update on ototoxicity: from a genetic perspective"],"prefix":"10.2131","volume":"50","author":[{"given":"Negar","family":"Akbari","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Tor Vergata University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Mahmoudi","family":"Lamooki","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Faculty of Agriculture, Ferdowsi University of Mashhad (FUM), Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood Rezvani","family":"Amin","sequence":"additional","affiliation":[{"name":"Health Promotion Research Center, Zahedan University Medical of Science, Zahedan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Emran","family":"Disnad","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Yousefinejad","sequence":"additional","affiliation":[{"name":"Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem","family":"Goharnia","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abi-Hachem, R.N., Zine, A. and Van De Water, T.R. (2010): The injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotectives strategies. Recent Patents CNS Drug Discov., <b>5<\/b>, 147-163.","DOI":"10.2174\/157488910791213121"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bacino, C., Prezant, T.R., Bu, X., Fournier, P. and Fischel-Ghodsian, N. (1995): Susceptibility mutations in the mitochondrial small ribosomal RNA gene in aminoglycoside induced deafness. Pharmacogenetics, <b>5<\/b>, 165-172.","DOI":"10.1097\/00008571-199506000-00005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Barbieri, M.A., Cicala, G., Cutroneo, P.M., Mocciaro, E., Sottosanti, L., Freni, F., Galletti, F., Arcoraci, V. and Spina, E. (2019): Ototoxic adverse drug reactions: a disproportionality analysis using the Italian spontaneous reporting database. Front. Pharmacol., <b>10<\/b>, 1161.","DOI":"10.3389\/fphar.2019.01161"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Borisova, T.V., Cherdonova, A.M., Pshennikova, V.G., Teryutin, F.M., Morozov, I.V., Bondar, A.A., Baturina, O.A., Kabilov, M.R., Romanov, G.P., Solovyev, A.V., Fedorova, S.A. and Barashkov, N.A. (2024): High prevalence of m.1555A\u2005&gt;\u2005G in patients with hearing loss in the Baikal Lake region of Russia as a result of founder effect. Sci. Rep., <b>14<\/b>, 15342.","DOI":"10.1038\/s41598-024-66254-z"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Borse, V., Al Aameri, R.F., Sheehan, K., Sheth, S., Kaur, T., Mukherjea, D., Tupal, S., Lowy, M., Ghosh, S., Dhukhwa, A., Bhatta, P., Rybak, L.P. and Ramkumar, V. (2017): Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity. Cell Death Dis., <b>8<\/b>, e2921.","DOI":"10.1038\/cddis.2017.314"},{"key":"6","doi-asserted-by":"crossref","unstructured":"B\u00f6ttger, E.C. and Schacht, J. (2013): The mitochondrion: a perpetrator of acquired hearing loss. Hear. Res., <b>303<\/b>, 12-19.","DOI":"10.1016\/j.heares.2013.01.006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Brock, P.R., Knight, K.R., Freyer, D.R., Campbell, K.C., Steyger, P.S., Blakley, B.W., Rassekh, S.R., Chang, K.W., Fligor, B.J., Rajput, K., Sullivan, M. and Neuwelt, E.A. (2012): Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. J. Clin. Oncol., <b>30<\/b>, 2408-2417.","DOI":"10.1200\/JCO.2011.39.1110"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Cacabelos, R., Naidoo, V., Corzo, L., Cacabelos, N. and Carril, J.C. (2021): Genophenotypic factors and pharmacogenomics in adverse drug reactions. Int. J. Mol. Sci., <b>22<\/b>, 13302.","DOI":"10.3390\/ijms222413302"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Cannizzaro, E., Cannizzaro, C., Plescia, F., et al. (2014): Exposure to ototoxic agents and hearing loss: A review of current knowledge. Hear. Balance Commun., <b>12<\/b>, 166-175.","DOI":"10.3109\/21695717.2014.964939"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Casano, R.A., Johnson, D.F., Bykhovskaya, Y., Torricelli, F., Bigozzi, M. and Fischel-Ghodsian, N. (1999): Inherited susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinical implications. Am. J. Otolaryngol., <b>20<\/b>, 151-156.","DOI":"10.1016\/S0196-0709(99)90062-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Cernada, M., P\u00e9rez-Aytes, A., Vento, M. and Mill\u00e1n, J.M. (2014): The genetics of aminoglycoside-related deafness. Neoreviews, <b>15<\/b>, e449-e457.","DOI":"10.1542\/neo.15-10-e449"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Chen, C., Chen, Y. and Guan, M.-X. (2015): A peep into mitochondrial disorder: multifaceted from mitochondrial DNA mutations to nuclear gene modulation. Protein Cell, <b>6<\/b>, 862-870.","DOI":"10.1007\/s13238-015-0175-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Ciarimboli, G., Deuster, D., Knief, A., Sperling, M., Holtkamp, M., Edemir, B., Pavenst\u00e4dt, H., Lanvers-Kaminsky, C., am Zehnhoff-Dinnesen, A., Schinkel, A.H., Koepsell, H., J\u00fcrgens, H. and Schlatter, E. (2010): Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. Am. J. Pathol., <b>176<\/b>, 1169-1180.","DOI":"10.2353\/ajpath.2010.090610"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Clemens, E., Broer, L., Langer, T., Uitterlinden, A.G., de Vries, A.C., van Grotel, M., Pluijm, S.F., Binder, H., Byrne, J., Broeder, E.V., Crocco, M., Grabow, D., Kaatsch, P., Kaiser, M., Kenborg, L., Winther, J.F., Rechnitzer, C., Hasle, H., Kepak, T., van der Kooi, A.F., Kremer, L.C., Kruseova, J., Kuehni, C.E., van der Pal, H., Parfitt, R., Deuster, D., Matulat, P., Spix, C., Tillmanns, A., Tissing, W.J., Maier, L., Am Zehnhoff-Dinnesen, A., Zolk, O. and van den Heuvel-Eibrink, M.M.; PanCareLIFE consortium. (2020): Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study. Pharmacogenomics J., <b>20<\/b>, 294-305.","DOI":"10.1038\/s41397-019-0113-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Coradini, P.P., Cigana, L., Selistre, S.G., Rosito, L.S. and Brunetto, A.L. (2007): Ototoxicity from cisplatin therapy in childhood cancer. J. Pediatr. Hematol. Oncol., <b>29<\/b>, 355-360.","DOI":"10.1097\/MPH.0b013e318059c220"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Dionne, F., Mitton, C., Rassekh, R., Brooks, B., Ross, C., Hayden, M. and Carleton, B. (2012): Economic impact of a genetic test for cisplatin-induced ototoxicity. Pharmacogenomics J., <b>12<\/b>, 205-213.","DOI":"10.1038\/tpj.2011.15"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Estivill, X., Govea, N., Barcel\u00f3, E., Badenas, C., Romero, E., Moral, L., Scozzri, R., D\u2019Urbano, L., Zeviani, M. and Torroni, A. (1998): Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment of aminoglycosides. Am. J. Hum. Genet., <b>62<\/b>, 27-35.","DOI":"10.1086\/301676"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Fischel-Ghodsian, N., Prezant, T.R., Bu, X. and \u00d6ztas, S. (1993): Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity. Am. J. Otolaryngol., <b>14<\/b>, 399-403.","DOI":"10.1016\/0196-0709(93)90113-L"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Forge, A. (2018): Ototoxicity. In: Scott-Brown\u2019s Otorhinolaryngology and Head and Neck Surgery), pp. 721-737, CRC Press.","DOI":"10.1201\/9780203731017-59"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Foster II, J. and Tekin, M. (2016): Aminoglycoside induced ototoxicity associated with mitochondrial DNA mutations. Egyptian Journal of Medical Human Genetics, <b>17<\/b>, 287\u2013293-287\u2013293.","DOI":"10.1016\/j.ejmhg.2016.06.001"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Frisina, R.D., Ding, B., Zhu, X. and Walton, J.P. (2016): Age-related hearing loss: prevention of threshold declines, cell loss and apoptosis in spiral ganglion neurons. Aging (Albany NY), <b>8<\/b>, 2081-2099.","DOI":"10.18632\/aging.101045"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Gaafar, D., Baxter, N., Cranswick, N., Christodoulou, J. and Gwee, A. (2024): Pharmacogenetics of aminoglycoside-related ototoxicity: a systematic review. J. Antimicrob. Chemother., <b>79<\/b>, 1508-1528.","DOI":"10.1093\/jac\/dkae106"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Gao, Z., Chen, Y. and Guan, M.-X. (2017): Mitochondrial DNA mutations associated with aminoglycoside induced ototoxicity. J. Otol., <b>12<\/b>, 1-8.","DOI":"10.1016\/j.joto.2017.02.001"},{"key":"24","unstructured":"Ghafari, N. (2023): Genetic and pharmacokinetics factors associated with susceptibility to kanamycin induced cochleotoxicity in a cohort of patients undergoing MDR\/RR-TB treatment."},{"key":"25","doi-asserted-by":"crossref","unstructured":"Gill, N.B., Dowker-Key, P.D., Hedrick, M. and Bettaieb, A. (2024): Unveiling the Role of Oxidative Stress in Cochlear Hair Cell Death: Prospective Phytochemical Therapeutics against Sensorineural Hearing Loss. Int. J. Mol. Sci., <b>25<\/b>, 4272.","DOI":"10.3390\/ijms25084272"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Guan, M.-X. (2011): Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity. Mitochondrion, <b>11<\/b>, 237-245.","DOI":"10.1016\/j.mito.2010.10.006"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Han, D., Dai, P., Zhu, Q., Liu, X., Huang, D., Yuan, Y., Yuan, H., Wang, X., Qian, Y., Young, W.Y. and Guan, M.X. (2007): The mitochondrial tRNA(Ala) T5628C variant may have a modifying role in the phenotypic manifestation of the 12S rRNA C1494T mutation in a large Chinese family with hearing loss. Biochem. Biophys. Res. Commun., <b>357<\/b>, 554-560.","DOI":"10.1016\/j.bbrc.2007.03.199"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Hazlitt, R.A., Teitz, T., Bonga, J.D., Fang, J., Diao, S., Iconaru, L., Yang, L., Goktug, A.N., Currier, D.G., Chen, T., Rankovic, Z., Min, J. and Zuo, J. (2018): Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss. J. Med. Chem., <b>61<\/b>, 7700-7709.","DOI":"10.1021\/acs.jmedchem.8b00669"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Hsieh, C.-Y., Tsai, C.-Y., Chou, Y.-F., Hsu, C.-J., Wu, H.-P. and Wu, C.-C. (2024): Otoprotection against aminoglycoside- and cisplatin-induced ototoxicity focusing on the upstream drug uptake pathway. J. Chin. Med. Assoc., <b>87<\/b>, 17-24.","DOI":"10.1097\/JCMA.0000000000001023"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Huth, M.E., Ricci, A.J. and Cheng, A.G. (2011): Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. Int. J. Otolaryngol., <b>2011<\/b>, 937861.","DOI":"10.1155\/2011\/937861"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Ibrahim, I., Dominguez-Valentin, M., Segal, B., Zeitouni, A. and da Silva, S.D. (2018): Mitochondrial mutations associated with hearing and balance disorders. Mutat. Res. Fundam. Mol. Mech. Mutagen., <b>810<\/b>, 39-44.","DOI":"10.1016\/j.mrfmmm.2018.03.003"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Igumnova, V., Veidemane, L., V\u012bksna, A., Capligina, V., Zole, E. and Ranka, R. (2019): The prevalence of mitochondrial mutations associated with aminoglycoside-induced deafness in ethnic Latvian population: the appraisal of the evidence. J. Hum. Genet., <b>64<\/b>, 199-206.","DOI":"10.1038\/s10038-018-0544-6"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Jiang, H., Sha, S.H., Forge, A. and Schacht, J. (2006): Caspase-independent pathways of hair cell death induced by kanamycin <i>in vivo.<\/i> Cell Death Differ., <b>13<\/b>, 20-30.","DOI":"10.1038\/sj.cdd.4401706"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Jing, W., Zongjie, H., Denggang, F., Na, H., Bin, Z., Aifen, Z., Xijiang, H., Cong, Y., Yunping, D., Ring, H.Z. and Ring, B.Z. (2015a): Mitochondrial mutations associated with aminoglycoside ototoxicity and hearing loss susceptibility identified by meta-analysis. J. Med. Genet., <b>52<\/b>, 95-103.","DOI":"10.1136\/jmedgenet-2014-102753"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Jing, W., Zongjie, H., Denggang, F., Na, H., Bin, Z., Aifen, Z., Xijiang, H., Cong, Y., Yunping, D., Ring, H.Z. and Ring, B.Z. (2015b): Mitochondrial mutations associated with aminoglycoside ototoxicity and hearing loss susceptibility identified by meta-analysis. J. Med. Genet., <b>52<\/b>, 95-103.","DOI":"10.1136\/jmedgenet-2014-102753"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Kessler, L., Koo, C., Richter, C.-P. and Tan, X. (2024): Hearing loss during chemotherapy: prevalence, mechanisms, and protection. Am. J. Cancer Res., <b>14<\/b>, 4597-4632.","DOI":"10.62347\/OKGQ4382"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Kim, S.J., Lee, J.H., Kim, B.S., So, H.S., Park, R., Myung, N.Y., Um, J.Y. and Hong, S.H. (2012): (-)-Epigallocatechin-3-gallate protects against NO-induced ototoxicity through the regulation of caspase- 1, caspase-3, and NF-\u03baB activation. PLoS One, <b>7<\/b>, e43967.","DOI":"10.1371\/journal.pone.0043967"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Konings, A., Van Camp, G., Goethals, A., Van Eyken, E., Vandevelde, A., Ben Azza, J., Peeters, N., Wuyts, W., Smeets, H. and Van Laer, L. (2008): Mutation analysis of mitochondrial DNA 12SrRNA and tRNASer(UCN) genes in non-syndromic hearing loss patients. Mitochondrion, <b>8<\/b>, 377-382.","DOI":"10.1016\/j.mito.2008.08.001"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Lala, M., Burckart, G.J., Takao, C.M., Pravica, V., Momper, J.D. and Gobburu, J.V. (2013): Genetics-based pediatric warfarin dosage regimen derived using pharmacometric bridging. J. Pediatr. Pharmacol. Ther., <b>18<\/b>, 209-219.","DOI":"10.5863\/1551-6776-18.3.209"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Langer, T., am Zehnhoff-Dinnesen, A., Radtke, S., Meitert, J. and Zolk, O. (2013): Understanding platinum-induced ototoxicity. Trends Pharmacol. Sci., <b>34<\/b>, 458-469.","DOI":"10.1016\/j.tips.2013.05.006"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Langer, T., Clemens, E., Broer, L., <i>et al<\/i>. (2020): Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study. European journal of cancer (Oxford, England: 1990), <b>138<\/b>, 212-224.","DOI":"10.1016\/j.ejca.2020.07.019"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Lanvers-Kaminsky, C., Sprowl, J.A., Malath, I., Deuster, D., Eveslage, M., Schlatter, E., Mathijssen, R.H., Boos, J., J\u00fcrgens, H., Am Zehnhoff-Dinnesen, A.G., Sparreboom, A. and Ciarimboli, G. (2015): Human OCT2 variant c.808G&gt;T confers protection effect against cisplatin-induced ototoxicity. Pharmacogenomics, <b>16<\/b>, 323-332.","DOI":"10.2217\/pgs.14.182"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Laurell, G., Viberg, A., Teixeira, M., Sterkers, O. and Ferrary, E. (2000): Blood-perilymph barrier and ototoxicity: an <i>in vivo<\/i> study in the rat. Acta Otolaryngol., <b>120<\/b>, 796-803.","DOI":"10.1080\/000164800750061624"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Le, T.A., Hiba, T., Chaudhari, D., Preston, A.N., Palowsky, Z.R., Ahmadzadeh, S., Shekoohi, S., Cornett, E.M. and Kaye, A.D. (2023): Aminoglycoside-related nephrotoxicity and ototoxicity in clinical practice: a review of pathophysiological mechanism and treatment options. Adv. Ther., <b>40<\/b>, 1357-1365.","DOI":"10.1007\/s12325-023-02436-x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Lee, C.K., Shin, J.I. and Cho, Y.S. (2011): Protective Effect of Minocycline Against Cisplatin-induced Ototoxicity. Clin. Exp. Otorhinolaryngol., <b>4<\/b>, 77-82.","DOI":"10.3342\/ceo.2011.4.2.77"},{"key":"46","unstructured":"Lee, J.W. (2014): A genome-wide association study of cisplatin-induced hearing loss in children.), University of British Columbia."},{"key":"47","doi-asserted-by":"crossref","unstructured":"L\u00e9v\u00eaque, M., Marlin, S., Jonard, L., Procaccio, V., Reynier, P., Amati-Bonneau, P., Baulande, S., Pierron, D., Lacombe, D., Duriez, F., Francannet, C., Mom, T., Journel, H., Catros, H., Drouin-Garraud, V., Obstoy, M.F., Dollfus, H., Eliot, M.M., Faivre, L., Duvillard, C., Couderc, R., Garabedian, E.N., Petit, C., Feldmann, D. and Denoyelle, F. (2007): Whole mitochondrial genome screening in maternally inherited non-syndromic hearing impairment using a microarray resequencing mitochondrial DNA chip. Eur. J. Hum. Genet., <b>15<\/b>, 1145-1155.","DOI":"10.1038\/sj.ejhg.5201891"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Li, H. and Steyger, P.S. (2011): Systemic aminoglycosides are trafficked via endolymph into cochlear hair cells. Sci. Rep., <b>1<\/b>, 159.","DOI":"10.1038\/srep00159"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Li, Q., Ji, Y., Han, B., Zong, L., Lan, L., Zhao, Y., Wang, H., Wang, D. and Wang, Q. (2014): Comparative study of mutation spectrums of MT-RNR1 m.1555A&gt;G, GJB2, and SLC26A4 between familial and sporadic patients with nonsyndromic sensorineural hearing loss in Chinese Han. Chin. Med. J. (Engl.), <b>127<\/b>, 3233-3237.","DOI":"10.1097\/00029330-201409200-00008"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Li, R., Xing, G., Yan, M., Cao, X., Liu, X.Z., Bu, X. and Guan, M.X. (2004): Cosegregation of C-insertion at position 961 with the A1555G mutation of the mitochondrial 12S rRNA gene in a large Chinese family with maternally inherited hearing loss. Am. J. Med. Genet. A., <b>124A<\/b>, 113-117.","DOI":"10.1002\/ajmg.a.20305"},{"key":"51","doi-asserted-by":"publisher","unstructured":"Liu, W., Staecker, H., Stupak, H., Malgrange, B., Lefebvre, P. and Van De Water, T.R. (1998): Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells. Neuroreport, <b>9<\/b>, 2609-2614.","DOI":"10.1097\/00001756-199808030-00034"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Lu, J., Qian, Y., Li, Z., Yang, A., Zhu, Y., Li, R., Yang, L., Tang, X., Chen, B., Ding, Y., Li, Y., You, J., Zheng, J., Tao, Z., Zhao, F., Wang, J., Sun, D., Zhao, J., Meng, Y. and Guan, M.X. (2010): Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness-associated 12S rRNA 1555A&gt;G mutation. Mitochondrion, <b>10<\/b>, 69-81.","DOI":"10.1016\/j.mito.2009.09.007"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Lui, G., Bouazza, N., Denoyelle, F., Moine, M., Brugi\u00e8res, L., Chastagner, P., Corradini, N., Entz-Werle, N., V\u00e9rit\u00e9, C., Landmanparker, J., Sudour-Bonnange, H., Pasquet, M., Verschuur, A., Faure-Conter, C., Doz, F. and Tr\u00e9luyer, J.M. (2018): Association between genetic polymorphisms and platinum-induced ototoxicity in children. Oncotarget, <b>9<\/b>, 30883-30893.","DOI":"10.18632\/oncotarget.25767"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Macedo, L.T., Costa, E.F., Carvalho, B.F., Louren\u00e7o, G.J., Calonga, L., Castilho, A.M., Chone, C.T. and Lima, C.S. (2023): Association of Clinical Aspects and Genetic Variants with the Severity of Cisplatin-Induced Ototoxicity in Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study. Cancers (Basel), <b>15<\/b>, 1759.","DOI":"10.3390\/cancers15061759"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Mamillapalli, C., Dhukhwa, A., Sheth, S., Mukherjea, D., Rybak, L.P. and Ramkumar, V. (2020): Review of ototoxic drugs and treatment strategies for reducing hearing loss. New Therapies to Prevent or Cure Auditory Disorders, 51-87.","DOI":"10.1007\/978-3-030-40413-0_3"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Monroe, J.D., Hodzic, D., Millay, M.H., Patty, B.G. and Smith, M.E. (2019): Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin. Molecules, <b>24<\/b>.","DOI":"10.3390\/molecules24213889"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Mukherjea, D., Dhukhwa, A., Sapra, A., Bhandari, P., Woolford, K., Franke, J., Ramkumar, V. and Rybak, L. (2020): Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity. Expert Opin. Drug Metab. Toxicol., <b>16<\/b>, 965-982.","DOI":"10.1080\/17425255.2020.1806235"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Nagai, J. and Takano, M. (2014): Entry of aminoglycosides into renal tubular epithelial cells via endocytosis-dependent and endocytosis-independent pathways. Biochem. Pharmacol., <b>90<\/b>, 331-337.","DOI":"10.1016\/j.bcp.2014.05.018"},{"key":"59","doi-asserted-by":"crossref","unstructured":"Neefs, J.-M., Van de Peer, Y., De Rijk, P., Goris, A. and De Wachter, R. (1991): Compilation of small ribosomal subunit RNA sequences. Nucleic Acids Res., <b>19<\/b> (Suppl), 1987-2015.","DOI":"10.1093\/nar\/19.suppl.1987"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Nguyen, T. and Jeyakumar, A. (2019): Genetic susceptibility to aminoglycoside ototoxicity. Int. J. Pediatr. Otorhinolaryngol., <b>120<\/b>, 15-19.","DOI":"10.1016\/j.ijporl.2019.02.002"},{"key":"61","doi-asserted-by":"crossref","unstructured":"Niu, P., Sun, Y., Wang, S., Li, G., Tang, X., Sun, J., Pan, C. and Sun, J. (2021): Puerarin alleviates the ototoxicity of gentamicin by inhibiting the mitochondria-dependent apoptosis pathway. Mol. Med. Rep., <b>24<\/b>.","DOI":"10.3892\/mmr.2021.12491"},{"key":"62","doi-asserted-by":"publisher","unstructured":"Noguchi, Y., Yashima, T., Ito, T., Sumi, T., Tsuzuku, T. and Kitamura, K. (2004): Audiovestibular findings in patients with mitochondrial A1555G mutation. Laryngoscope, <b>114<\/b>, 344-348.","DOI":"10.1097\/00005537-200402000-00031"},{"key":"63","doi-asserted-by":"crossref","unstructured":"Olivero, O.A., Chang, P.K., Lopez-Larraza, D.M., Semino-Mora, M.C. and Poirier, M.C. (1997): Preferential formation and decreased removal of cisplatin-DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA. Mutat. Res., <b>391<\/b>, 79-86.","DOI":"10.1016\/S0165-1218(97)00037-2"},{"key":"64","doi-asserted-by":"crossref","unstructured":"Pasdelou, M.-P., Byelyayeva, L., Malmstr\u00f6m, S., Pucheu, S., Peytavy, M., Laullier, H., Hodges, D.B. Jr., Tzafriri, A.R. and Naert, G. (2024): Ototoxicity: a high risk to auditory function that needs to be monitored in drug development. Front. Mol. Neurosci., <b>17<\/b>, 1379743.","DOI":"10.3389\/fnmol.2024.1379743"},{"key":"65","doi-asserted-by":"crossref","unstructured":"Pasquariello, K.Z., Dey, J.M. and Sprowl, J.A. (2021): Current understanding of membrane transporters as regulators or targets for cisplatin-induced hearing loss. Mol. Pharmacol., <b>100<\/b>, 348-355.","DOI":"10.1124\/molpharm.121.000274"},{"key":"66","doi-asserted-by":"crossref","unstructured":"Pfaff, A.R., Beltz, J., King, E. and Ercal, N. (2020): Medicinal thiols: current status and new perspectives. Mini Rev. Med. Chem., <b>20<\/b>, 513-529.","DOI":"10.2174\/1389557519666191119144100"},{"key":"67","doi-asserted-by":"crossref","unstructured":"Pham, V.H., Nguyen, V.L., Jung, H.E., Cho, Y.S. and Shin, J.G. (2022): The frequency of the known mitochondrial variants associated with drug-induced toxicity in a Korean population. BMC Med. Genomics, <b>15<\/b>, 3.","DOI":"10.1186\/s12920-021-01153-0"},{"key":"68","doi-asserted-by":"crossref","unstructured":"Press\u00e9, M.T., Malgrange, B. and Delacroix, L. (2023): The cochlear matrisome: importance in hearing and deafness. Matrix Biol.","DOI":"10.1016\/j.matbio.2023.12.002"},{"key":"69","unstructured":"Pussegoda, K. (2012): The pharmacogenomics of cisplatin-induced hearing loss.), University of British Columbia."},{"key":"70","doi-asserted-by":"crossref","unstructured":"Pussegoda, K., Ross, C.J., Visscher, H., Yazdanpanah, M., Brooks, B., Rassekh, S.R., Zada, Y.F., Dub\u00e9, M.P., Carleton, B.C. and Hayden, M.R.; CPNDS Consortium. (2013): Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children. Clin. Pharmacol. Ther., <b>94<\/b>, 243-251.","DOI":"10.1038\/clpt.2013.80"},{"key":"71","doi-asserted-by":"crossref","unstructured":"Quintanilha, J.C., Saavedra, K.F., Visacri, M.B., Moriel, P. and Salazar, L.A. (2019): Role of epigenetic mechanisms in cisplatin-induced toxicity. Crit. Rev. Oncol. Hematol., <b>137<\/b>, 131-142.","DOI":"10.1016\/j.critrevonc.2019.03.004"},{"key":"72","doi-asserted-by":"crossref","unstructured":"Rabi\u00e7o-Costa, D., Gil-da-Costa, M.J., Barbosa, J.P., Bom-Sucesso, M. and Spratley, J. (2020): Platinum-drugs ototoxicity in pediatric patients with brain tumors: a 10-year review. J. Pediatr. Hematol. Oncol., <b>42<\/b>, e25-e31.","DOI":"10.1097\/MPH.0000000000001637"},{"key":"73","doi-asserted-by":"crossref","unstructured":"Rajput, K., Akhtar, U., Pagarkar, W., Rajput, S., Walder, C., D\u2019Arco, F., Cochrane, L., Nash, R., Bitner-Glindzicz, M. and Omar, R. (2024): Etiology of Childhood Profound Sensorineural Hearing Loss: The Role of Hearing Loss Gene Panel Testing. Otolaryngol. Head Neck Surg., <b>171<\/b>, 1518-1525.","DOI":"10.1002\/ohn.838"},{"key":"74","doi-asserted-by":"publisher","unstructured":"Reynard, P. and Thai-Van, H. (2024): Drug-induced hearing loss: listening to the latest advances. Therapies, <b>79<\/b>, 283-295.","DOI":"10.1016\/j.therap.2023.10.011"},{"key":"75","doi-asserted-by":"crossref","unstructured":"Rivetti, S., Romano, A., Mastrangelo, S., Attin\u00e0, G., Maurizi, P. and Ruggiero, A. (2023): Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients. Pharmaceuticals (Basel), <b>16<\/b>, 1353.","DOI":"10.3390\/ph16101353"},{"key":"76","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Ballesteros, M., Olarte, M., Aguirre, L.A., Gal\u00e1n, F., Gal\u00e1n, R., Vallejo, L.A., Navas, C., Villamar, M., Moreno-Pelayo, M.A., Moreno, F. and del Castillo, I. (2006): Molecular and clinical characterisation of three Spanish families with maternally inherited non-syndromic hearing loss caused by the 1494C-&gt;T mutation in the mitochondrial 12S rRNA gene. J. Med. Genet., <b>43<\/b>, e54-e54.","DOI":"10.1136\/jmg.2006.042440"},{"key":"77","doi-asserted-by":"crossref","unstructured":"Rosenberg, C.R., Fang, X. and Allison, K.R. (2020): Potentiating aminoglycoside antibiotics to reduce their toxic side effects. PLoS One, <b>15<\/b>, e0237948.","DOI":"10.1371\/journal.pone.0237948"},{"key":"78","doi-asserted-by":"crossref","unstructured":"Ross, C.J., Katzov-Eckert, H., Dub\u00e9, M.-P., Brooks, B., Rassekh, S.R., Barhdadi, A., Feroz-Zada, Y., Visscher, H., Brown, A.M., Rieder, M.J., Rogers, P.C., Phillips, M.S., Carleton, B.C. and Hayden, M.R.; CPNDS Consortium. (2009a): Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nat. Genet., <b>41<\/b>, 1345-1349.","DOI":"10.1038\/ng.478"},{"key":"79","doi-asserted-by":"crossref","unstructured":"Ross, C.J., Katzov-Eckert, H., Dub\u00e9, M.P., Brooks, B., Rassekh, S.R., Barhdadi, A., Feroz-Zada, Y., Visscher, H., Brown, A.M., Rieder, M.J., Rogers, P.C., Phillips, M.S., Carleton, B.C. and Hayden, M.R.; CPNDS Consortium. (2009b): Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nat. Genet., <b>41<\/b>, 1345-1349.","DOI":"10.1038\/ng.478"},{"key":"80","doi-asserted-by":"crossref","unstructured":"Rybak, L.P. and Ramkumar, V. (2007): Ototoxicity. Kidney Int., <b>72<\/b>, 931-935.","DOI":"10.1038\/sj.ki.5002434"},{"key":"81","doi-asserted-by":"crossref","unstructured":"Rybak, L.P. (1993): Ototoxicity of loop diuretics. Otolaryngol. Clin. North Am., <b>26<\/b>, 829-844.","DOI":"10.1016\/S0030-6665(20)30770-2"},{"key":"82","doi-asserted-by":"crossref","unstructured":"Rybak, L.P. (2007): Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr. Opin. Otolaryngol. Head Neck Surg., <b>15<\/b>, 364-369.","DOI":"10.1097\/MOO.0b013e3282eee452"},{"key":"83","doi-asserted-by":"crossref","unstructured":"Rybak, L.P., Mukherjea, D. and Ramkumar, V. (2019): Mechanisms of cisplatin-induced ototoxicity and prevention. In: Seminars in hearing), pp. 197-204, Thieme Medical Publishers.","DOI":"10.1055\/s-0039-1684048"},{"key":"84","doi-asserted-by":"crossref","unstructured":"Rybak, L.P., Whitworth, C.A., Mukherjea, D. and Ramkumar, V. (2007): Mechanisms of cisplatin-induced ototoxicity and prevention. Hear. Res., <b>226<\/b>, 157-167.","DOI":"10.1016\/j.heares.2006.09.015"},{"key":"85","doi-asserted-by":"crossref","unstructured":"Schacht, J., Talaska, A.E. and Rybak, L.P. (2012): Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat. Rec. (Hoboken), <b>295<\/b>, 1837-1850.","DOI":"10.1002\/ar.22578"},{"key":"86","doi-asserted-by":"crossref","unstructured":"Selimoglu, E. (2007): Aminoglycoside-induced ototoxicity. Curr. Pharm. Des., <b>13<\/b>, 119-126.","DOI":"10.2174\/138161207779313731"},{"key":"87","doi-asserted-by":"crossref","unstructured":"Shi, X., Dong, Y., Li, Y., Zhao, Z., Li, H., Qiu, S., Li, Y., Guo, W. and Qiao, Y. (2015): Inflammasome activation in mouse inner ear in response to MCMV induced hearing loss. J. Otol., <b>10<\/b>, 143-149.","DOI":"10.1016\/j.joto.2015.12.001"},{"key":"88","doi-asserted-by":"crossref","unstructured":"Shinde, A., Wilmanski, T., Chen, H., Teegarden, D. and Wendt, M.K. (2018): Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer. Breast Cancer Res., <b>20<\/b>, 76.","DOI":"10.1186\/s13058-018-1008-9"},{"key":"89","doi-asserted-by":"crossref","unstructured":"Someya, S. and Kim, M.-J. (2021): Cochlear detoxification: role of alpha class glutathione transferases in protection against oxidative lipid damage, ototoxicity, and cochlear aging. Hear. Res., <b>402<\/b>, 108002.","DOI":"10.1016\/j.heares.2020.108002"},{"key":"90","doi-asserted-by":"crossref","unstructured":"Steyger, P.S. (2021a): Mechanisms of aminoglycoside-and cisplatin-induced ototoxicity. Am. J. Audiol., <b>30<\/b> (3S), 887-900.","DOI":"10.1044\/2021_AJA-21-00006"},{"key":"91","doi-asserted-by":"crossref","unstructured":"Steyger, P.S. (2021b): Mechanisms of ototoxicity and otoprotection. Otolaryngol. Clin. North Am., <b>54<\/b>, 1101-1115.","DOI":"10.1016\/j.otc.2021.08.007"},{"key":"92","doi-asserted-by":"crossref","unstructured":"Talach, T., Rottenberg, J., G\u00e1l, B., Kostrica, R., Jurajda, M., Kocak, I., Lakomy, R. and Vogazianos, E. (2016): Genetic risk factors of cisplatin induced ototoxicity in adult patients. Neoplasma, <b>63<\/b>, 263-268.","DOI":"10.4149\/212_140820N391"},{"key":"93","doi-asserted-by":"crossref","unstructured":"Tan, W.J. and Song, L. (2023): Role of mitochondrial dysfunction and oxidative stress in sensorineural hearing loss. Hear. Res., <b>434<\/b>, 108783.","DOI":"10.1016\/j.heares.2023.108783"},{"key":"94","doi-asserted-by":"crossref","unstructured":"Tang, D., Wang, X., Wu, J., Li, Y., Li, C., Qiao, X., Fan, L., Chen, Y., Zhu, H., Zhang, Z. and He, Y. (2024): Cinchonine and cinchonidine alleviate cisplatin-induced ototoxicity by regulating PI3K-AKT signaling. CNS Neurosci. Ther., <b>30<\/b>, e14403.","DOI":"10.1111\/cns.14403"},{"key":"95","doi-asserted-by":"crossref","unstructured":"Thiesen, S., Yin, P., Jorgensen, A.L., Zhang, J.E., Manzo, V., McEvoy, L., Barton, C., Picton, S., Bailey, S., Brock, P., Vyas, H., Walker, D., Makin, G., Bandi, S., Pizer, B., Hawcutt, D.B. and Pirmohamed, M. (2017): TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity. Pharmacogenet. Genomics, <b>27<\/b>, 213-222.","DOI":"10.1097\/FPC.0000000000000281"},{"key":"96","doi-asserted-by":"crossref","unstructured":"Thomas, J.P., Lautermann, J., Liedert, B., Seiler, F. and Thomale, J. (2006): High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity. Mol. Pharmacol., <b>70<\/b>, 23-29.","DOI":"10.1124\/mol.106.022244"},{"key":"97","doi-asserted-by":"crossref","unstructured":"Thyagarajan, D., Bressman, S., Bruno, C., Przedborski, S., Shanske, S., Lynch, T., Fahn, S. and DiMauro, S. (2000): A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Ann. Neurol., <b>48<\/b>, 730-736.","DOI":"10.1002\/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0"},{"key":"98","doi-asserted-by":"crossref","unstructured":"Tran Ba Huy, P., Bernard, P. and Schacht, J. (1986): Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs. J. Clin. Invest., <b>77<\/b>, 1492-1500.","DOI":"10.1172\/JCI112463"},{"key":"99","doi-asserted-by":"crossref","unstructured":"Truong, M.T., Winzelberg, J. and Chang, K.W. (2007): Recovery from cisplatin-induced ototoxicity: a case report and review. Int. J. Pediatr. Otorhinolaryngol., <b>71<\/b>, 1631-1638.","DOI":"10.1016\/j.ijporl.2007.06.021"},{"key":"100","doi-asserted-by":"crossref","unstructured":"Tserga, E., Nandwani, T., Edvall, N.K., Bulla, J., Patel, P., Canlon, B., Cederroth, C.R. and Baguley, D.M. (2019): The genetic vulnerability to cisplatin ototoxicity: a systematic review. Sci. Rep., <b>9<\/b>, 3455.","DOI":"10.1038\/s41598-019-40138-z"},{"key":"101","doi-asserted-by":"crossref","unstructured":"Ungur, R.A., Borda, I.M., Codea, R.A., Ciortea, V.M., N\u0103sui, B.A., Muste, S., Sarpataky, O., Filip, M., Irsay, L., Cr\u0103ciun, E.C., C\u0103inap, S., Jiv\u0103nescu, D.B., Pop, A.L., Singurean, V.E., Cri\u0219an, M., Groza, O.B. and Marti\u0219 Petru\u021b, G.S. (2022): A flavonoid-rich extract of Sambucus nigra L. reduced lipid peroxidation in a rat experimental model of gentamicin nephrotoxicity. Materials (Basel), <b>15<\/b>, 772.","DOI":"10.3390\/ma15030772"},{"key":"102","doi-asserted-by":"crossref","unstructured":"Usami, S., Abe, S., Akita, J., Namba, A., Shinkawa, H., Ishii, M., Iwasaki, S., Hoshino, T., Ito, J., Doi, K., Kubo, T., Nakagawa, T., Komiyama, S., Tono, T. and Komune, S. (2000): Prevalence of mitochondrial gene mutations among hearing impaired patients. J. Med. Genet., <b>37<\/b>, 38-40.","DOI":"10.1136\/jmg.37.1.38"},{"key":"103","doi-asserted-by":"crossref","unstructured":"Vermorken, J.B., Kapteijn, T.S., Hart, A.A. and Pinedo, H.M. (1983): Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration. Eur. J. Cancer Clin. Oncol., <b>19<\/b>, 53-58.","DOI":"10.1016\/0277-5379(83)90398-X"},{"key":"104","doi-asserted-by":"crossref","unstructured":"Wang, J., Ladrech, S., Pujol, R., Brabet, P., Van De Water, T.R. and Puel, J.L. (2004): Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss. Cancer Res., <b>64<\/b>, 9217-9224.","DOI":"10.1158\/0008-5472.CAN-04-1581"},{"key":"105","doi-asserted-by":"crossref","unstructured":"Wang, J. and Puel, J.-L. (2018): Toward cochlear therapies. Physiol. Rev., <b>98<\/b>, 2477-2522.","DOI":"10.1152\/physrev.00053.2017"},{"key":"106","doi-asserted-by":"crossref","unstructured":"Wang, Q., Li, Q.-Z., Han, D., Zhao, Y., Zhao, L., Qian, Y., Yuan, H., Li, R., Zhai, S., Young, W.Y. and Guan, M.X. (2006): Clinical and molecular analysis of a four-generation Chinese family with aminoglycoside-induced and nonsyndromic hearing loss associated with the mitochondrial 12S rRNA C1494T mutation. Biochem. Biophys. Res. Commun., <b>340<\/b>, 583-588.","DOI":"10.1016\/j.bbrc.2005.12.045"},{"key":"107","doi-asserted-by":"crossref","unstructured":"Wang, X., Zhou, Y., Wang, D., Wang, Y., Zhou, Z., Ma, X., Liu, X. and Dong, Y. (2023): Cisplatin-induced ototoxicity: from signaling network to therapeutic targets. Biomed. Pharmacother., <b>157<\/b>, 114045.","DOI":"10.1016\/j.biopha.2022.114045"},{"key":"108","doi-asserted-by":"crossref","unstructured":"Weissenstein, A., Deuster, D., Knief, A., Zehnhoff-Dinnesen, A.A. and Schmidt, C.M. (2012): Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy. Int. J. Pediatr. Otorhinolaryngol., <b>76<\/b>, 131-136.","DOI":"10.1016\/j.ijporl.2011.10.020"},{"key":"109","doi-asserted-by":"crossref","unstructured":"Xie, J., Talaska, A.E. and Schacht, J. (2011): New developments in aminoglycoside therapy and ototoxicity. Hear. Res., <b>281<\/b>, 28-37.","DOI":"10.1016\/j.heares.2011.05.008"},{"key":"110","doi-asserted-by":"crossref","unstructured":"Xie, L., Zhou, Q., Chen, X., Du, X., Liu, Z., Fei, B., Hou, J., Dai, Y. and She, W. (2021): Elucidation of the Hdac2\/Sp1\/<i>miR-204-5p<\/i>\/<i>Bcl-2<\/i> axis as a modulator of cochlear apoptosis via <i>in vivo<\/i>\/<i>in vitro<\/i> models of acute hearing loss. Mol. Ther. Nucleic Acids, <b>23<\/b>, 1093-1109.","DOI":"10.1016\/j.omtn.2021.01.017"},{"key":"111","doi-asserted-by":"crossref","unstructured":"Xu, Y., Bei, Z., Li, M., Qiu, K., Ren, J., Chu, B., Zhao, Y. and Qian, Z. (2024): Biomaterials for non-invasive trans-tympanic drug delivery: requirements, recent advances and perspectives. J. Mater. Chem. B, <b>12<\/b>, 7787-7813.","DOI":"10.1039\/D4TB00676C"},{"key":"112","doi-asserted-by":"crossref","unstructured":"Yang, Z., Schumaker, L.M., Egorin, M.J., Zuhowski, E.G., Guo, Z. and Cullen, K.J. (2006): Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis. Clin. Cancer Res., <b>12<\/b>, 5817-5825.","DOI":"10.1158\/1078-0432.CCR-06-1037"},{"key":"113","doi-asserted-by":"crossref","unstructured":"Zhao, H., Young, W.-Y., Yan, Q., Li, R., Cao, J., Wang, Q., Li, X., Peters, J.L., Han, D. and Guan, M.X. (2005): Functional characterization of the mitochondrial 12S rRNA C1494T mutation associated with aminoglycoside-induced and non-syndromic hearing loss. Nucleic Acids Res., <b>33<\/b>, 1132-1139.","DOI":"10.1093\/nar\/gki262"},{"key":"114","doi-asserted-by":"crossref","unstructured":"Zhao, L., Young, W.-Y., Li, R., Wang, Q., Qian, Y. and Guan, M.-X. (2004): Clinical evaluation and sequence analysis of the complete mitochondrial genome of three Chinese patients with hearing impairment associated with the 12S rRNA T1095C mutation. Biochem. Biophys. Res. Commun., <b>325<\/b>, 1503-1508.","DOI":"10.1016\/j.bbrc.2004.10.199"},{"key":"115","doi-asserted-by":"crossref","unstructured":"Zou, S., Zheng, Q., Sun, Y., Fu, X., Zhou, W. and He, Z. (2024): Editorial: Gene therapy for hearing loss: from mechanism to clinic, volume II. Front. Neurosci., <b>18<\/b>, 1412981.","DOI":"10.3389\/fnins.2024.1412981"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/50\/6\/50_245\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:45:59Z","timestamp":1749271559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/50\/6\/50_245\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":115,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.50.245","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}